共 50 条
- [22] Identification of biomarkers, pathways, and therapeutic targets for EGFR-TKI resistance in NSCLCLIFE SCIENCE ALLIANCE, 2023, 6 (12)Zhu, LeileiGao, ShanshanZhao, XianyaWang, Ying
- [23] The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell linesANNALS OF ONCOLOGY, 2016, 27Perez, A.Castiglia, M.Passiglia, F.Barraco, N.Cangemi, A.Fanale, D.Listi, A.Maragliano, R.Massihnia, D.Di Piazza, F.Vieni, S.Calo, V.Rizzo, S.Incorvaia, L.Bazan, V.Russo, A.
- [24] Clinicopathological features and immune microenvironment of NSCLC with primary resistance to EGFR-TKICANCER SCIENCE, 2018, 109 : 1101 - 1101Takashima, YutaSakakibara-Konishi, JunHatanaka, YutakaHatanaka, Kanako C.Ohhara, YoshihitoOizumi, SatoshiHida, YasuhiroKaga, KichizoKinoshita, IchiroDosaka-Akita, HirotoshiMatsuno, YoshihiroNishimura, Masaharu
- [25] Deep Proteomic and Phosphoproteomic Analysis of NSCLC EGFR-TKI-Resistance MechanismsLABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1071 - 1071Namba, KeiTanaka, AtsushiOgawa, MakikoHendrickson, RonaldKlimstra, DavidToyooka, ShinichiRoehrl, Michael
- [26] The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKIJOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S208 - S209Lu, S.Wang, Q.Zhang, G.Dong, X.Yang, C.Song, Y.Chang, G.Lu, Y.Pan, H.Chiu, C.Wang, Z.Feng, J.Zhou, J.Xu, X.Guo, R.Chen, J.Yang, H.Chen, Y.Yu, Z.Shiah, H.Wang, C.Yang, N.Fang, J.Wang, P.Wang, K.Hu, Y.He, J.Wang, Z.Shi, J.Chen, S.Cheng, Y.Su, W.Hsia, T.Cui, J.Sun, Y.Yang, C.
- [27] Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKIONCOLOGY LETTERS, 2018, 15 (01) : 901 - 907Cheong, Hio TengXu, FeiChoy, Chi TungHui, Connie Wun ChunMok, Tony Shu KamWong, Chi Hang
- [28] Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLCCANCERS, 2022, 14 (16)Novak, JenniferSalgia, RaviWest, HowardVillalona-Calero, Miguel A.Sampath, SagusWilliams, TerenceVillaflor, VictoriaMassarelli, ErminiaPathak, RanjanKoczywas, MariannaChau, BrittneyAmini, Arya
- [29] Deep Proteomic and Phosphoproteomic Analysis of NSCLC EGFR-TKI-Resistance MechanismsMODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1071 - 1071Namba, KeiTanaka, AtsushiOgawa, MakikoHendrickson, RonaldKlimstra, DavidToyooka, ShinichiRoehrl, Michael
- [30] Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLCScientific Reports, 12Kenichi KoyamaSatoru MiuraSatoshi WatanabeSatoshi ShojiJun KoshioYoshiki HayashiDaisuke IshikawaKo SatoTakao MiyabayashiMasaaki OkajimaTakeshi OtaTomohiro TanakaNaoya MatsumotoHideyuki KuriyamaTetsuya AbeKoichiro NozakiKosuke IchikawaRie KondoHiroshi TanakaToshiaki Kikuchi